[Federal Register Volume 88, Number 216 (Thursday, November 9, 2023)]
[Notices]
[Page 77325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24756]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to 
participate and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: December 8, 2023.
    Time: 9:00 a.m. to 4:00 p.m. EST.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and improvements in patients' and their families' lives. The agenda 
for this meeting will be available on the MDCC website: https://www.mdcc.nih.gov/.
    Registration: To register, please go to: https://forms.roseliassociates.com/view.php?id=84779.
    Webcast Live: https://videocast.nih.gov/.
    Place: Neuroscience Center Building (NSC), Room 1131, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Glen Nuckolls, Ph.D., Program Director, National 
Institute of Neurological Disorders and Stroke (NINDS), NIH, 6001 
Executive Blvd., Rm 2203, Bethesda, MD 20892, 301-496-5876, 
<a href="/cdn-cgi/l/email-protection#efa2abacacaf818687c1888099"><span class="__cf_email__" data-cfemail="7d30393e3e3d131415531a120b">[email protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee home page: https://mdcc.nih.gov/.

    Dated: November 3, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-24756 Filed 11-8-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>